Biocare Medical is proud to announce the launch of RISH™

A new, innovative, chromogenic ISH technology: reducing protocol length from two days to approximately 2.5 hours. In a simplified protocol we have removed the need for RNase free solutions & labware, the overnight hybridization and harsh stringent wash conditions. The proprietary DNA probe technology ensures high specificity and accuracy for the target. The result is […]

Understanding FISH vs NGS Capabilities

In the rapidly changing laboratory landscape, there are many valuable techniques that identify and produce different amounts of diagnostic information. In this white paper, discover the power of FISH and NGS. Learn how these techniques can be used to identify genetic abnormalities, perform genome-wide analysis, and detect disease-related variants. Understand the advantages and disadvantages of […]

Biocare Medical and Ensigna Biosystems Announce Strategic Partnership to Drive Spatial Biology, Multiomic Enablement, and Innovation in Biotechnology

[San Francisco, California, September 4, 2024] – Biocare Medical, a global leader in immunohistochemistry (IHC) instrumentation and reagents, together with Ensigna Biosystems, a renowned provider of advanced histopathology services, are excited to announce a new strategic partnership. This collaboration seeks to enable and broaden the scope of innovative spatial biology applications that are essential for […]

FISH and Cytogenetic Analysis: Probing for CLL and MDS

Fluorescence in situ hybridization (FISH) probes have become a cornerstone of cytogenetic analysis in hematological malignancies. These targeted probes allow for the detection of specific chromosomal abnormalities associated with various leukemias and myelodysplastic syndromes (MDS). This white paper will explore the importance of FISH probes for Chronic Lymphocytic Leukemia (CLL) and Myelodysplastic Syndromes (MDS)

Probing Questions: DNA Probes vs RNA Probes vs cDNA Probes

Nucleic acid probes are invaluable tools in molecular biology, enabling clinical laboratories and researchers to detect specific DNA or RNA sequences within a sample. In this white paper, we explore the key differences between three prominent probe types: DNA probes, RNA probes, and cDNA probes. We delve into their what they are, how they are […]

Characterizing Cancers: Utilizing IHC Panels to Identify Tumors of Unknown Primary Sites

The use of a curated selection of antibodies to target protein characteristics of distinct cell lineages has been in practice in clinical laboratories for many years. The ability for pathologists to identify cells of unknown origin via the use of Immunohistochemistry (IHC) is extremely important to aid in the diagnosis, treatment, and prognosis for their […]

Empire Genomics Corp. awarded Molecular Analyzers, Reagents agreement with Premier, Inc.

Buffalo, New York – April 1, 2024 – Empire Genomics Corp has been awarded a national group purchasing agreement for Molecular Analyzers, Reagents with Premier, Inc. Effective 02/01/2024, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for FISH (Fluorescent in situ Hybridization) Probes. […]

Meet the Marker: CD54 (ICAM-1)

Cluster of Differentiation 54 (CD54), also known as Intercellular Adhesion Molecule 1 (ICAM-1), is a 90 kDa glycosylated transmembrane protein of the immunoglobulin superfamily. CD54 (ICAM-1) can play an important role in immunological synapse formation, T-cell activation, leukocyte migration, and numerous cellular immune responses.1 CD54 (ICAM-1) also interacts with integrin receptors on leukocytes, such as […]

Biocare Medical and Molecular Instruments Partner to Revolutionize Automated Bioimaging through ONCORE Pro X and HCR™ RNA-ISH Assays

[San Francisco, California, January 4, 2024] – Biocare Medical, a leader in fully open automated instrumentation, announces a collaboration with Molecular Instruments® (MI), the inventor of the HCR™ Imaging technology. This partnership brings together Biocare Medical’s expertise in automated bioimaging systems with MI’s suite of advanced HCR™ Products, setting a new standard in automated in […]

Probing Questions: What are the 5’ and 3’ ends of DNA?

The 5′ and 3′ ends of DNA are fundamental to its structure and function, particularly in the process of DNA replication. These structural ends are also significant in a variety of molecular biology techniques, including Fluorescence in Situ Hybridization (FISH), a clinical testing method used to detect and study genetic abnormalities.

Biocare Medical Unveils intelliPATH+: Next-Generation Enhancement of the Proven intelliPATH FLX Staining System

November 30, 2023* – Biocare Medical, a leader in immunohistochemistry (IHC) and in situ hybridization (ISH) diagnostics, is proud to introduce the intelliPATH+ Advanced Staining Instrument. This state-of-the-art upgrade solidifies Biocare Medical’s dedication to superior automated IHC staining processes and marks a significant expansion of its advanced, automated staining portfolio, which includes the acclaimed ONCORE […]

Email Cart